Departments and Centres

The UCL Cancer Institute is structured as five departments: Cancer Biology, Haematology, Oncology, Pathology and Clinical trials. The Institute works in partnerships with specialist Centres that cut across both Institute departments and wider UCL departments and divisions to further collaboration and interdisciplinary research.

Research Departments

Department of Cancer Biology
Department of Haematology: Lorem ipsum

Link
Department of Oncology: Lorem Ipsum
Department of Pathology: Lorem Ipsum
Clinical Trials: Cancer Research UK UCL Clinical Trials Centre (CTC)

The CTC is one of the largest cancer trials centres in the UK, and one of the nine accredited clinical trials units of the National Cancer Research Institute. The CTC coordinates national and international cancer trials.

UCLH/UCL Clinical Research Facility

Specialist Centres and Collaborations

Bill Lyons Informatics Centre: The Bill Lyons Informatics Centre focuses on genomics studies, from cancer classification to personal genomics and patient stratification.
Cancer Research UK-UCL Centre: The Cancer Research UK Centre at UCL is part of a national network of centres funded by Cancer Research UK dedicated to delivering world-leading research, improved patient care and greater local engagement.
Cancer Research UK Lung Centre of Excellence: The CRUK Lung Cancer Centre of Excellence at Manchester and UCL brings together the unique and complementary strengths of our partner organisations to create a collaborative environment in which integrated lung cancer research can flourish.
Experimental Cancer Research Centre (ECMC): The Experimental Cancer Medicine Centre (ECMC) Network is a unique UK-wide initiative jointly funded by Cancer Research UK and UK Health Departments. UCL ECMC is committed to performing world-class clinical cancer research to develop new cancer therapies.
Comprehensive Cancer Imaging Centre (CCIC): The Comprehensive Cancer Imaging Centre (CCIC) is a major collaboration between King's College London and UCL, supported by funding from Cancer Research UK, Engineering & Physical Sciences Research Council, Medical Research Council and Department of Health (England).